Effects of Aminoguanidine on Glucagon and Insulin Release from Rat Pancreatic Islet

Endocrine Journal

Volumn 43, Issue 6, 1996, Pages 725-730

  Tasaka, Yoshimasa ^a   Nakaya, Humio ^a   Omori, Yasue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Aminoguanidine; Glucagon; Insulin; Pancreatic islets

Indexed keywords

AMINOGUANIDINE; ARGININE; CHOLECYSTOKININ; ENZYME INHIBITOR; GLUCAGON; GUANIDINE DERIVATIVE; INSULIN;

ANIMAL; ARTICLE; CULTURE TECHNIQUE; DRUG EFFECT; KINETICS; PANCREAS ISLET; RAT; SECRETION;

ANIMALS; ARGININE; CHOLECYSTOKININ; CULTURE TECHNIQUES; ENZYME INHIBITORS; GLUCAGON; GUANIDINES; INSULIN; ISLETS OF LANGERHANS; KINETICS; RATS;

EID: 0030342720     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.725     Document Type: Article

References (24)

1. Yagihashi S, Kamijo M, Baba M, Yagihashi N, Nagai K (1992) Effect of aminoguanidine on functional and structual abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41:47-52.
2. Soules-Liparota T, Cooper M, Parazoglou D, Clark B, Jerumes G (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40: 1328-1335.
3. Ellis EN, Good BH (1991) Prevention of glomerular basement thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40: 1016-1019.
4. Edelstein D, Brownlee M (1992) Aminoguanidine ameliolates albuminuria in diabetic hypertensive rats. Diabetologia 35: 96-97.
5. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster Jr. JR, Williamson JR, Daniel ML (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556.
6. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, Mcdaniel ML, Williamson JR (1993) Prevention of diabetic vascular dysfunction by guanidine. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42: 221-232.
7. Tasaka Y, Nakaya F, Matsumoto H, Ohgawara H, Omori Y (1992) Effects of aminoguanidine on the insulin secretion from rat pancreatic islets. Peptide Hormones in Pancreas 12: 55-58 (In Japanese).
8. Zähner D, Malaisse WJ (1992) Effects of advanced glycation products and aminoguanidine upon insulin release. Diab Nutr Metab 5: 43-46.
9. Tasaka Y, Nakaya F, Matsumoto H, Omori Y (1994) Effects of aminoguanidine on insulin release from pancreatic islets. Endocr J 41: 309-313.
10. Lacy PE, Kostianovsky M (1967) Method for isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39.
11. Tasaka Y, Matsumoto H, Inoue Y, Mochizuki N, Hirata Y (1991) Plasma insulin and glucagon and their release from pancreatic islet in hyperosmolar diabetic rat. Endocrinol Japon 38: 53-59.
12. Morgan CR, Lazarow A (1963) Immunoassay of insulin: Two antibody system plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12: 115-126.
13. Unger RH, Ketterer H, Dupre J, Eisentraut AM (1967) The effects of secretin, pancreozymin and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest 46: 630-645.
14. Iversen J (1971) Secretion of glucagon from the isolated, perfused canine pancreas. J Clin Invest 50: 2123-2136.
15. Ohneda A, Parada E, Eisentraut AM, Unger RH (1968) Characterization of response of circulating glucagon to intraduodenal and intravenous adminsitration of amino acids. J Clin Invest 47: 2305-2322.
16. Plamer JP, Benson JW, Walter RM, Ensinck JW (1976) Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest 58: 565-570.
17. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soldner JS, Eisenbarth GS (1984) Differential sensitivity to β-cell secretagogues in "Early" Type 1 diabetes mellitus. Diabetes 33: 516-521.
18. Dunger A, Cunningham JM, Delaney CA, Lowe JE, Green MHL, Bone AJ, Green IC (1996) Tumor necrosis factor-α and interferon-γ inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Diabetes 45: 183-189.
19. Misko TP, Moore WN, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, William JR, Currie MG (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233: 119-125.
20. Bowman M, Simell O, Look Z, Luchetta R, Atkinson M (1994) Pharmacokinetic and therapeutic analysis of aminoguanidine (AG) in non-obese diabetic (NOD) mice. Diabetes (Suppl 1): 43: 235A.
21. Jansson I, Sandler S (1991) The nitric oxide synthase II inhibitor N-nitro-I-arginine stimulates pancreatic islet insulin release in vitro but not in the perfused pancreas. Endocrinology 128: 3081-3085.
22. Baylin S, Horakova Z, Beaven MA (1975) Increase in food consumption and growth after treatment with aminoguanidine. Experientia 31: 562-564.
23. Hutton JC, Sener A, Hersculez A, Valverde I, Boschero AC, Malaisse WJ (1980) The stimulus secretion coupling of glucose-induced insulin release, XL II. Effects of extracellular pH on insulin release: Their dependency on nutrient concentration. Harm Metab Res 12: 294-299.
24. Holstad M, Jansson L, Sandler S (1996) Effects of aminoguanidine on rat pancreatic islets in culture and on the pancreatic islet blood flow of anaesthetized rats. Biochem pharmacol 51: 1711-1717.